Skip to Content

American Funds Europacific Growth R4 REREX

Medalist Rating as of | See American Funds Investment Hub
  • NAV / 1-Day Return 56.54  /  +0.16 %
  • Total Assets 137.2 Bil
  • Adj. Expense Ratio
    0.820%
  • Expense Ratio 0.820%
  • Distribution Fee Level Low
  • Share Class Type Retirement, Medium
  • Category Foreign Large Growth
  • Investment Style Large Growth
  • Min. Initial Investment 250
  • Status Open
  • TTM Yield 1.63%
  • Turnover 34%

USD | NAV as of Jul 23, 2024 | 1-Day Return as of Jul 23, 2024, 10:18 PM GMT+0

Morningstar’s Analysis REREX

Will REREX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

An impressive option.

Senior Analyst Stephen Welch

Stephen Welch

Senior Analyst

Summary

American Funds EuroPacific Growth's management talent, strong analytical resources, and flexible approach make it one of the most attractive options within the foreign large-growth Morningstar Category.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings REREX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 25.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

5.29 7.2 Bil
Healthcare

Taiwan Semiconductor Manufacturing Co Ltd

4.52 6.1 Bil
Technology

Capital Group Central Cash Fund

3.37 4.6 Bil
Cash and Equivalents

SAP SE

2.15 2.9 Bil
Technology

ASML Holding NV

2.13 2.9 Bil
Technology

Reliance Industries Ltd

2.08 2.8 Bil
Energy

Airbus SE

2.03 2.8 Bil
Industrials

Safran SA

1.95 2.7 Bil
Industrials

Daiichi Sankyo Co Ltd

1.79 2.4 Bil
Healthcare

Glencore PLC

1.62 2.2 Bil
Basic Materials